欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体

Anti-PAI-1 mAbs

简要描述:

This antibody binds human PAI-1 in the hI‐s5A loop comprising amino acid residues 300 to 314 (RQFQADFTSLSDQ). Plasminogen activator inhibitor-1 (PAI-1), is a serine protease inhibitor, a unique member of the serpin superfamily which plays an important role in fibrinolysis and is an established risk factor for cardiovascular diseases. It a primary inhibitor of tissue-type plasminogen activator (PLAT) and urokinase-type plasminogen activator (PLAU). As PLAT inhibitor, it is required for fibrinolysis down-regulation and is responsible for the controlled degradation of blood clots. As PLAU inhibitor, it is involved in the regulation of cell adhesion and spreading .

产品参数:

Cat. No.:MABL-2597

Species:Engineer

Species Reactivity:Human

Type:Recombinate

Application:functional assay, inhibit, neutralize

详细介绍

Key features and   details


Cat. No.

MABL-2597

Name

Anti-PAI-1 mAbs

Clone No.

AFD-Nb64 (VHH-2w-64)

From

Recombinant Antibody

Isotype

Engineer antibody

Application

functional assay,   inhibit, neutralize

Species Reactivity

Human

Basic Information


Specificity

This antibody binds   human PAI-1 in the hIs5A loop comprising amino acid residues 300 to 314 (RQFQADFTSLSDQ).   Plasminogen activator inhibitor-1 (PAI-1), is a serine protease inhibitor, a   unique member of the serpin superfamily which plays an important role in   fibrinolysis and is an established risk factor for cardiovascular diseases.   It a primary inhibitor of tissue-type plasminogen activator (PLAT) and   urokinase-type plasminogen activator (PLAU). As PLAT inhibitor, it is required for fibrinolysis down-regulation and is responsible for the controlled   degradation of blood clots. As PLAU inhibitor, it is involved in the   regulation of cell adhesion and spreading .

Alternative Name

SERPINE1; PAI1; PAI;   PLANH1; Plasminogen activator inhibitor 1; Endothelial plasminogen activator   inhibitor; Serpin E1

UniProt

P05121

Immunogen

The original antibody   was isolated from a nanobody library generated by immunization of three   alpacas with three different PAI-1 variants.

Application Notes

This antibody is capable   of inhibiting both glycosylated and non-glycosylated PAI-1 variants through a   substrate-inducing mechanism. The profibrinolytic effect of this antibody was   confirmed using an in vitro clot lysis assay (PMID: 27604413). This antibody   neutralized PAI-1 by redirecting (95-97%) of the reaction with two chain (tc)   tPA and uPA plasminogen activators to the substrate branch. This antibody was   less effective with single chain proenzymes (Komissarov et al, 2019).

Antibody First   Published

Zhou et al. Generation   and in vitro characterization of inhibitory nanobodies towards plasminogen   activator inhibitor 1. Thromb Haemost. 2016 Nov   30;116(6):1032-1040. PMID:27604413

Note on publication

Describes the generation   of 5 inhibitory nanobodies against PAI-1.

COA Information For reference only, actual COA shall prevail

Size

100 μg Purified   antibody.

Concentration

1 mg/ml.

Purification

Protein A affinity   purified

Buffer

PBS with 0.02% Proclin   300.

Concentration

1 mg/ml.

Storage   Recommendation

Store at 4⁰C for up to 3   months. For longer storage, aliquot and store at - 20⁰C.


 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

上一篇: Anti-PAI-1 mAbs

下一篇:没有了

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号